Results 21 to 30 of about 1,588,451 (244)
PD-L1 sensitivity and specificity of antibody clone 29E.2A3 for PD-L1.
A.Western blot of cell lysates from cultured human breast cancer cell lines known to express (MDA-MB-231) or not to express PD-L1 (MCF-7) using E1L3N Rabbit mAb, confirming the PD-L1 status of these two cell lines. B.
James M. Rae (7876037) +15 more
core +1 more source
The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. [PDF]
The balance between pro-inflammatory and regulatory immune responses in determining optimal T cell activation is vital for the successful resolution of microbial infections.
Couper, Kevin N +44 more
core +1 more source
Western Blot PD-L1 expression after XVir-N-31-anti-PD-L1 infection.pdf
PD-L1 expression of HEK cells after XVir-N-31-anti-PD-L1 infection.
Moritz Klawitter (13177230)
core +1 more source
Binding and inhibition assays of anti-PD-L1 antibody.
(A) Specific binding to human PD-L1 by ELISA. The Tecentriq® and human IgG1 was used as positive and negative control respectively. Plant-produced anti-PD-1 antibody was also used to confirm the non-specificity to PD-L1.
Thareeya Phetphoung (14106521) +11 more
core +1 more source
Programmed cell death ligand 1 (PD-L1) is widely expressed in a variety of human tumors, and inhibition of the PD-L1/PD-1 pathway represents one of the most promising therapy for many types of cancer.
Ruirui Wang +8 more
doaj +1 more source
The immune checkpoint pathway consisting of the cell membrane-bound molecule programmed death protein 1 (PD-1) and its ligand PD-L1 has been found to mediate negative regulatory signals that effectively inhibit T-cell proliferation and function and ...
Mengke Niu +5 more
doaj +1 more source
Antibody blockade of the PD-1/PD-L1 pathway has elicited durable antitumor responses in the therapy of a broad spectrum of cancers. PD-L1 is constitutively expressed in certain tumors and host immune cells, and its expression can be induced or maintained
Fei Tang, Pan Zheng
doaj +1 more source
PD-L1 blockade after XVir-N-31-anti-PD-L1 infection.pzfx
PD-L1 blockade assay
Moritz Klawitter (13177230)
core +1 more source
Cancer immunotherapy targeting programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) pathway has shown promising results in treatment of non-small cell lung cancer (NSCLC) patients.
Dina M. El-Guindy +3 more
doaj +1 more source
Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
Recent data have suggested that PD-1 and PD-L1 are involved in osteosarcoma (OS) pathogenesis; however, their contributions are not well-established. Here, the PD-1/PD-L1 expression was evaluated in (OS) cases.
Kazuhiko Hashimoto +2 more
doaj +1 more source

